Department of Nephrology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
Division of Nephrology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
Front Immunol. 2022 Oct 13;13:973169. doi: 10.3389/fimmu.2022.973169. eCollection 2022.
Activation of the alternative pathway (AP) of complement is thought to play an important role in Immunoglobin A nephropathy (IgAN). Our previous study showed that rs4151657 within the complement factor B () gene increased the risk of IgAN. The protein encoded by the gene is an initial factor that promotes AP activation. The aim of this study was to investigate whether other variants of confer susceptibility to IgAN and elucidate their potential roles in AP activation. A total of 1,350 patients with IgAN and 1,420 healthy controls were enrolled and five tag single-nucleotide polymorphisms were selected for genotyping. The levels of key AP components, such as CFB, complement factor H and complement split product C3a, were measured by enzyme-linked immunosorbent assay. Molecular docking and molecular dynamic simulation were carried out to characterize the mutation of residues in the protein structure and the dynamic properties of wide type and mutation models of CFB protein. The allele-specific effect on CFB expression and its binding affinity to C3b were investigated through cell transfection and surface plasmon resonance analysis, respectively. We found that rs12614 significantly reduced the risk of IgAN (OR = 0.69, 95% CI = 0.52-0.91, = 0.009), and the rs12614-T (R32W mutation) was correlated with lower CFB levels, higher serum C3 level, and less mesangial C3 deposition in patients with IgAN. The structural model showed that the R32W mutation reduced the structural stability of CFB protein. Furthermore, study revealed that rs12614-T decreased the expression of CFB and reduced its binding affinity to C3b by four-fold compared with rs12614-C. In conclusion, the rs12614-T in was associated with low risk of IgAN probably by attenuating AP activation.
补体替代途径(AP)的激活被认为在免疫球蛋白 A 肾病(IgAN)中发挥重要作用。我们之前的研究表明,补体因子 B()基因内的 rs4151657 增加了 IgAN 的风险。基因编码的蛋白是促进 AP 激活的初始因子。本研究旨在探讨其他 基因变异是否与 IgAN 的易感性相关,并阐明其在 AP 激活中的潜在作用。共纳入 1350 例 IgAN 患者和 1420 例健康对照者,选择 5 个标签单核苷酸多态性进行基因分型。通过酶联免疫吸附试验测定关键 AP 成分(如 CFB、补体因子 H 和补体分裂产物 C3a)的水平。进行分子对接和分子动力学模拟,以描述蛋白质结构中残基的突变以及 CFB 蛋白的野生型和突变模型的动态特性。通过细胞转染和表面等离子体共振分析分别研究等位基因对 CFB 表达及其与 C3b 结合亲和力的特异性影响。我们发现 rs12614 显著降低了 IgAN 的风险(OR = 0.69,95%CI = 0.52-0.91, = 0.009),rs12614-T(R32W 突变)与 IgAN 患者的 CFB 水平较低、血清 C3 水平较高和系膜 C3 沉积较少相关。结构模型表明,R32W 突变降低了 CFB 蛋白的结构稳定性。此外,研究表明,与 rs12614-C 相比,rs12614-T 降低了 CFB 的表达,并使其与 C3b 的结合亲和力降低了四倍。总之,rs12614-T 可能通过减弱 AP 激活与 IgAN 的低风险相关。